Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hamufare Mugauri"'
Publikováno v:
International Journal of Infectious Diseases, Vol 76, Iss , Pp 6-13 (2018)
Objective: To quantify and assess trends and risk factors for loss to follow-up (LTFU) and delays before treatment initiation among bacteriologically confirmed pulmonary tuberculosis (TB) patients (laboratory-diagnosed) in Bulawayo, 2012–16. Design
Externí odkaz:
https://doaj.org/article/a151c1c56ff246ae98e0a8be01b71ce3
Autor:
Hamufare Mugauri, Mufuta Tshimanga, Owen Mugurungi, Tsitsi Juru, Notion Gombe, Gerald Shambira
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0200459 (2018)
INTRODUCTION:Key to pharmacovigilance is spontaneously reporting all Adverse Drug Reactions (ADR) during post-market surveillance. This facilitates the identification and evaluation of previously unreported ADR's, acknowledging the trade-off between
Externí odkaz:
https://doaj.org/article/8ea0976a8bbf4c0d9ded56ce9ae106f1
Autor:
Hamufare Mugauri, Owen Mugurungi, Addmore Chadambuka, Tsitsi Juru, Notion Tafara Gombe, Gerald Shambira, Mufuta Tshimanga
Publikováno v:
AIDS Research and Treatment, Vol 2018 (2018)
Background. In 2016, Mashonaland West Province had 7.4% (520) dried blood spot (DBS) samples for early infant diagnosis (EID) rejected by the Zimbabwe National Microbiology Reference Laboratory (NMRL). The samples were suboptimal, delaying treatment
Externí odkaz:
https://doaj.org/article/14b3c5b42ba44ad0a33a4a980a10f8d4
Autor:
Hamufare Mugauri, Riitta A Dlodlo, Palanivel Chinnakali, Evidence Gaka, Blessing Masunungure, Alois Mandizvidza, Shepherd Nyambi, Davison Garauzive, Freeman Dube, Joseph Nembaware
Publikováno v:
Tuberculosis Research and Treatment
Tuberculosis Research and Treatment, Vol 2020 (2020)
Tuberculosis Research and Treatment, Vol 2020 (2020)
Setting. Zimbabwe is a high tuberculosis (TB) burden country, with an estimated prevalence of 344/100,000 population. Though prisons are known high-prevalence sites for TB, the paucity of data affects the quantification of the disease and treatment o
Autor:
George Mavunganidze, Menard Mutenherwa, Philip Owiti, Tonderai Mapako, Hamufare Mugauri, Lucy M. Marowa, Riitta A Dlodlo, David Zezai, Palanivel Chinnakali
Publikováno v:
Journal of Biosciences and Medicines. :35-43
Background: Low level of transfusion transmissible infections (TTIs) is an indicator of a well-performing blood donor program. Aim: The study was designed to estimate the prevalence of TTIs and to evaluate the demographic characteristics of reactive
Autor:
Hamufare Mugauri (Dumisani), Joconiah Chirenda, Tsitsi Juru, Owen Mugurungi, Gerald Shambira, Notion Gombe, Mufuta Tshimanga
Publikováno v:
IJID Regions (Online). 3
To investigate determinants of drug resistance and treatment outcomes among patients with drug-resistant tuberculosis (DR-TB).This was a cross-sectional study on patients diagnosed with DR-TB in Bulawayo and Matabeleland South provinces, 2015.A total
Publikováno v:
International Journal of Infectious Diseases, Vol 76, Iss, Pp 6-13 (2018)
Objective: To quantify and assess trends and risk factors for loss to follow-up (LTFU) and delays before treatment initiation among bacteriologically confirmed pulmonary tuberculosis (TB) patients (laboratory-diagnosed) in Bulawayo, 2012–16. Design
Autor:
Mufuta Tshimanga, Tsitsi Juru, Owen Mugurungi, Notion Tafara Gombe, Hamufare Mugauri, Gerald Shambira
Publikováno v:
Open Journal of Preventive Medicine. :138-150
Background: In 2009, Zimbabwe incorporated Voluntary Medical Male Circumcision (VMMC) to a consortium of measures to eliminate HIV transmission by 2030. Seke and Goromonzi districts simultaneously commenced implementing VMMC. These districts have com
Autor:
Owen Mugurungi, Hamufare Mugauri, Tsitsi Juru, Mufuta Tshimanga, Gerald Shambira, Notion Tafara Gombe
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0200459 (2018)
PLoS ONE, Vol 13, Iss 12, p e0200459 (2018)
IntroductionKey to pharmacovigilance is spontaneously reporting all Adverse Drug Reactions (ADR) during post-market surveillance. This facilitates identification and evaluation of previously unreported ADR’s, acknowledging the trade-off between ben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::027c459adb76a4f8cbb645482ecb10f1
https://doi.org/10.1101/358069
https://doi.org/10.1101/358069
Autor:
Tsitsi Juru, Notion Tafara Gombe, Mufuta Tshimanga, Gerald Shambira, Owen Mugurungi, Hamufare Mugauri, Addmore Chadambuka
Publikováno v:
AIDS Research and Treatment, Vol 2018 (2018)
AIDS Research and Treatment
AIDS Research and Treatment
Background. In 2016, Mashonaland West Province had 7.4% (520) dried blood spot (DBS) samples for early infant diagnosis (EID) rejected by the Zimbabwe National Microbiology Reference Laboratory (NMRL). The samples were suboptimal, delaying treatment